Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['dara ', 'mmsm']
#mmsm #asco23 single arm studies in car-t are problematic, here we have rct which is something good design screen failures (n= ~100), why? median follow up: 16 mo ~1 out of 4 patients are dara refractory more info in the upcoming comment 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities